琥珀酸美托洛尔缓释片治疗心梗后室性心律失常的临床效果与价值体会  

Clinical Effect and Value of Metoprolol Succinate Sustained-Release Tablets in the Treatment of Ventricular Arrhythmia after Myocardial Infarction

作　　者：李海静[1] LI Hai-jing(Internal Medicine-Cardiovascular Department,Taiyuan People's Hospital,Taiyuan,Shanxi 030001)

机构地区：[1]太原市人民医院心内科

出　　处：《智慧健康》2019年第35期179-180,186,共3页Smart Healthcare

摘　　要：目的研究探讨琥珀酸美托洛尔缓释片治疗心梗后室性心律失常的临床效果与价值体会。方法选取我院2017年1月至2019年1月收治的心梗后室性心律失常患者94例作为研究对象,随机分为两组后给予不同治疗方案展开临床治疗,其中研究组行琥珀酸美托洛尔缓释片治疗,对照组行常规治疗,统计记录两组患者接受治疗后QTd、QTcd指标改善情况以及临床疗效,并进行对比。结果两组患者经过不同治疗后,研究组QTd、QTcd指标参数均优于对照组患者,其临床疗效高于对照组患者,以上对比均具有统计学意义(P<0.05)。结论琥珀酸美托洛尔缓释片应用在心梗后室性心律失常的临床治疗中,其能有效提高心梗后室性心律失常临床治疗有效,因此,值得临床推广。Objective To study the clinical effect and value of metoprolol succinate sustained-release tablets in the treatment of ventricular arrhythmia after myocardial infarction.Methods Ninety-four patients with ventricular arrhythmia after myocardial infarction admitted to our hospital from January 2017 to January 2019 were randomly divided into two groups and treated with different treatment plans.Among them,the study group was treated with metoprolol succinate sustained-release tablets,and the control group was treated with routine treatment.The improvement of QTd and QTcd indexes and clinical data were recorded.The curative effect was compared.Results After different treatment,the parameters of QTd and QTcd in the study group were better than those in the control group,and the clinical effect was higher than that in the control group.The above comparison was statistically significant(P<0.05).Conclusion Metoprolol succinate sustained-release tablets can effectively improve the clinical treatment of ventricular arrhythmia after myocardial infarction,so it is worthy of clinical promotion.

关 键 词：心梗后室性心律失常 琥珀酸美托洛尔缓释片 临床疗效 

分 类 号：R542.22[医药卫生—心血管疾病] R541.7[医药卫生—内科学]